MG
Meditor Group Portfolio holdings
AUM
$48.1M
This Quarter Return
+12.94%
1 Year Return
+38.67%
3 Year Return
+41.15%
5 Year Return
+72.2%
10 Year Return
+1,065.64%
AUM
$533M
AUM Growth
+$533M
(+9.9%)
Cap. Flow
-$39.7M
Cap. Flow
% of AUM
-7.44%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
3
Increased
–
Reduced
2
Closed
–
Top Buys
| 1 |
ProShares UltraShort S&P500
SDS
|
$3.83M |
| 2 |
ProShares UltraPro Short S&P 500
SPXU
|
$3.31M |
| 3 |
ProShares UltraPro Short QQQ
SQQQ
|
$2.9M |
Top Sells
| 1 |
Celldex Therapeutics
CLDX
|
$29M |
| 2 |
Exelixis
EXEL
|
$20.7M |
Sector Composition
| 1 | Healthcare | 94.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Exelixis
EXEL
$10.1B
| $359M | 67.36% | 15,094,495 -871,543 | -5% | -$20.7M |
|
2
Esperion Therapeutics
ESPR
$448M
| $108M | 20.17% | 2,679,835 | – | – |
|
3
Alkermes
ALKS
$4.78B
| $32.6M | 6.11% | 892,400 | – | – |
|
4
iShares MSCI India ETF
INDA
$9.17B
| $11.3M | 2.12% | 320,000 | – | – |
|
5
WisdomTree India Earnings Fund ETF
EPI
$2.86B
| $10.5M | 1.97% | 400,000 | – | – |
|
|
6
ProShares UltraShort S&P500
SDS
$445M
| $3.83M | 0.72% | +115,000 | New | +$3.83M |
|
|
7
ProShares UltraPro Short S&P 500
SPXU
$527M
| $3.31M | 0.62% | +105,000 | New | +$3.31M |
|
|
8
ProShares UltraPro Short QQQ
SQQQ
$2.39B
| $2.9M | 0.54% | +285,000 | New | +$2.9M |
|
|
9
Celldex Therapeutics
CLDX
$1.47B
| $2.07M | 0.39% | 420,846 -5,891,854 | -93% | -$29M |
|